29 Nov

Antitrust and life sciences in the United States – navigating the pitfalls

A slew of recent lawsuits and legislation challenging the allegedly anti-competitive nature of US pharma patent enforcement strategies has made it more important than ever for IP professionals in this space to watch out for the hazards

Adam Houldsworth

Life sciences reporter


[email protected]